Priority 14 from the Psoriatic Arthritis PSP
| UNCERTAINTY: What is best way of predicting and preventing joint and soft tissue damage in patients with psoriatic arthritis? (JLA PSP Priority 14) | |
|---|---|
| Overall ranking | 14 |
| JLA question ID | 0108/14 |
| Explanatory note | This question explores whether healthcare professionals can predict which people living with psoriatic arthritis will develop joint or soft tissue damage. Also, if we can identify these people, can we recommend specific treatments (drug or non-drug) to prevent the person from developing joint or soft tissue damage? For example, which patients will develop erosive disease? Can exercise prevent erosive disease? Which approach is best suited to predict the likelihood of developing permanent joint or soft tissue damage? |
| Evidence |
This is an area of uncertainty. No systematic reviews or guidelines identified. |
| Health Research Classification System category | Inflammatory and immune system |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | How can we tell which patients will not develop joint damage? |
| Submitted by | 12 uncertainties submitted |
| PSP information | |
|---|---|
| PSP unique ID | 0108 |
| PSP name | Psoriatic Arthritis |
| Total number of uncertainties identified by this PSP. | 46 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 12 July 2021 |